12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
During Thursday's after-market session, several healthcare stocks experienced significant movement. Biolase (BIOL), Impel Pharmaceuticals (IMPL), Axcella Health (AXLA), Avalo Therapeutics (AVTX), Bullfrog AI Hldgs (BFRG), and Achilles Therapeutics (ACHL) saw their stocks rise, while Generation Bio (GBIO), Perspective Therapeutics (CATX), Revelation Biosciences (REVB), Cardio Diagnostics Hldgs (CDIO), Journey Medical (DERM), and China SXT Pharmaceuticals (SXTC) experienced a decrease in their stock prices.
September 07, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biolase's stock rose by 30.4% to $4.12 during Thursday's after-market session.
The significant increase in Biolase's stock price indicates positive market sentiment towards the company, which could lead to further increases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Impel Pharmaceuticals' stock rose by 15.2% to $0.44.
The rise in Impel Pharmaceuticals' stock price suggests positive investor sentiment, which could drive further increases in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Perspective Therapeutics' stock fell by 7.97% to $0.37.
The fall in Perspective Therapeutics' stock price suggests negative investor sentiment, which could drive further decreases in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Generation Bio's stock decreased by 10.1% to $4.17 during Thursday's after-market session.
The decrease in Generation Bio's stock price indicates negative market sentiment, which could lead to further decreases in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100